Clinical trial
A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides
NCT00002114 is registered in ClinicalTrials.gov with Free Radical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides
- Lead sponsor
- Free Radical Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- January 31, 1994
- Enrollment
- 125
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.